Comparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's Lymphoma

Clinical trial NCT00060671 · TERMINATED

Trial details

NCT number: NCT00060671
Sponsor: CTI BioPharma
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Lymphoma, Follicular Lymphoma, Mixed-Cell, Follicular Lymphoma, Small Cleaved-Cell, Follicular Lymphoma, Low-Grade

Start date: 2005-01-01
Primary completion: 2006-01-01
Enrollment: 800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.